Glass Processing Equipment Market In Global
Glass Processing Equipment is a series of completing processing lines. Tempered glass, laminated ... Read More
Biopharmaceuticals Market - Global Outlook and Forecast 2023-2028
1 Introduction to Research & Analysis Reports
1.1 Biopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biopharmaceuticals Overall Market Size
2.1 Global Biopharmaceuticals Market Size: 2021 VS 2028
2.2 Global Biopharmaceuticals Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biopharmaceuticals Players in Global Market
3.2 Top Global Biopharmaceuticals Companies Ranked by Revenue
3.3 Global Biopharmaceuticals Revenue by Companies
3.4 Top 3 and Top 5 Biopharmaceuticals Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biopharmaceuticals Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biopharmaceuticals Players in Global Market
3.6.1 List of Global Tier 1 Biopharmaceuticals Companies
3.6.2 List of Global Tier 2 and Tier 3 Biopharmaceuticals Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Biopharmaceuticals Market Size Markets, 2021 & 2028
4.1.2 Monoclonal Antibodies
4.1.3 Interferon
4.1.4 Colony-Stimulating Factor
4.1.5 Erythropoietin
4.1.6 Insulin
4.1.7 Vaccines
4.1.8 Growth Hormones
4.1.9 Others
4.2 By Type - Global Biopharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global Biopharmaceuticals Revenue, 2017-2022
4.2.2 By Type - Global Biopharmaceuticals Revenue, 2023-2028
4.2.3 By Type - Global Biopharmaceuticals Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biopharmaceuticals Market Size, 2021 & 2028
5.1.2 Tumor
5.1.3 Diabetes
5.1.4 Cardiovascular
5.1.5 Hemophilia
5.1.6 Others
5.2 By Application - Global Biopharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global Biopharmaceuticals Revenue, 2017-2022
5.2.2 By Application - Global Biopharmaceuticals Revenue, 2023-2028
5.2.3 By Application - Global Biopharmaceuticals Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Biopharmaceuticals Market Size, 2021 & 2028
6.2 By Region - Global Biopharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global Biopharmaceuticals Revenue, 2017-2022
6.2.2 By Region - Global Biopharmaceuticals Revenue, 2023-2028
6.2.3 By Region - Global Biopharmaceuticals Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Biopharmaceuticals Revenue, 2017-2028
6.3.2 US Biopharmaceuticals Market Size, 2017-2028
6.3.3 Canada Biopharmaceuticals Market Size, 2017-2028
6.3.4 Mexico Biopharmaceuticals Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Biopharmaceuticals Revenue, 2017-2028
6.4.2 Germany Biopharmaceuticals Market Size, 2017-2028
6.4.3 France Biopharmaceuticals Market Size, 2017-2028
6.4.4 U.K. Biopharmaceuticals Market Size, 2017-2028
6.4.5 Italy Biopharmaceuticals Market Size, 2017-2028
6.4.6 Russia Biopharmaceuticals Market Size, 2017-2028
6.4.7 Nordic Countries Biopharmaceuticals Market Size, 2017-2028
6.4.8 Benelux Biopharmaceuticals Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Biopharmaceuticals Revenue, 2017-2028
6.5.2 China Biopharmaceuticals Market Size, 2017-2028
6.5.3 Japan Biopharmaceuticals Market Size, 2017-2028
6.5.4 South Korea Biopharmaceuticals Market Size, 2017-2028
6.5.5 Southeast Asia Biopharmaceuticals Market Size, 2017-2028
6.5.6 India Biopharmaceuticals Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Biopharmaceuticals Revenue, 2017-2028
6.6.2 Brazil Biopharmaceuticals Market Size, 2017-2028
6.6.3 Argentina Biopharmaceuticals Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biopharmaceuticals Revenue, 2017-2028
6.7.2 Turkey Biopharmaceuticals Market Size, 2017-2028
6.7.3 Israel Biopharmaceuticals Market Size, 2017-2028
6.7.4 Saudi Arabia Biopharmaceuticals Market Size, 2017-2028
6.7.5 UAE Biopharmaceuticals Market Size, 2017-2028
7 Players Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Biopharmaceuticals Major Product Offerings
7.1.4 Roche Biopharmaceuticals Revenue in Global Market (2017-2022)
7.1.5 Roche Key News
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Biopharmaceuticals Major Product Offerings
7.2.4 Amgen Biopharmaceuticals Revenue in Global Market (2017-2022)
7.2.5 Amgen Key News
7.3 AbbVie
7.3.1 AbbVie Corporate Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Biopharmaceuticals Major Product Offerings
7.3.4 AbbVie Biopharmaceuticals Revenue in Global Market (2017-2022)
7.3.5 AbbVie Key News
7.4 Sanofi-Aventis
7.4.1 Sanofi-Aventis Corporate Summary
7.4.2 Sanofi-Aventis Business Overview
7.4.3 Sanofi-Aventis Biopharmaceuticals Major Product Offerings
7.4.4 Sanofi-Aventis Biopharmaceuticals Revenue in Global Market (2017-2022)
7.4.5 Sanofi-Aventis Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Biopharmaceuticals Major Product Offerings
7.5.4 Johnson & Johnson Biopharmaceuticals Revenue in Global Market (2017-2022)
7.5.5 Johnson & Johnson Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Biopharmaceuticals Major Product Offerings
7.6.4 Pfizer Biopharmaceuticals Revenue in Global Market (2017-2022)
7.6.5 Pfizer Key News
7.7 Novo Nordisk
7.7.1 Novo Nordisk Corporate Summary
7.7.2 Novo Nordisk Business Overview
7.7.3 Novo Nordisk Biopharmaceuticals Major Product Offerings
7.7.4 Novo Nordisk Biopharmaceuticals Revenue in Global Market (2017-2022)
7.7.5 Novo Nordisk Key News
7.8 Eli Lilly
7.8.1 Eli Lilly Corporate Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Biopharmaceuticals Major Product Offerings
7.8.4 Eli Lilly Biopharmaceuticals Revenue in Global Market (2017-2022)
7.8.5 Eli Lilly Key News
7.9 Novartis
7.9.1 Novartis Corporate Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Biopharmaceuticals Major Product Offerings
7.9.4 Novartis Biopharmaceuticals Revenue in Global Market (2017-2022)
7.9.5 Novartis Key News
7.10 Merck
7.10.1 Merck Corporate Summary
7.10.2 Merck Business Overview
7.10.3 Merck Biopharmaceuticals Major Product Offerings
7.10.4 Merck Biopharmaceuticals Revenue in Global Market (2017-2022)
7.10.5 Merck Key News
7.11 Sun
7.11.1 Sun Corporate Summary
7.11.2 Sun Business Overview
7.11.3 Sun Biopharmaceuticals Major Product Offerings
7.11.4 Sun Biopharmaceuticals Revenue in Global Market (2017-2022)
7.11.5 Sun Key News
7.12 3sbio
7.12.1 3sbio Corporate Summary
7.12.2 3sbio Business Overview
7.12.3 3sbio Biopharmaceuticals Major Product Offerings
7.12.4 3sbio Biopharmaceuticals Revenue in Global Market (2017-2022)
7.12.5 3sbio Key News
7.13 Changchun High Tech
7.13.1 Changchun High Tech Corporate Summary
7.13.2 Changchun High Tech Business Overview
7.13.3 Changchun High Tech Biopharmaceuticals Major Product Offerings
7.13.4 Changchun High Tech Biopharmaceuticals Revenue in Global Market (2017-2022)
7.13.5 Changchun High Tech Key News
7.14 CP Guojian
7.14.1 CP Guojian Corporate Summary
7.14.2 CP Guojian Business Overview
7.14.3 CP Guojian Biopharmaceuticals Major Product Offerings
7.14.4 CP Guojian Biopharmaceuticals Revenue in Global Market (2017-2022)
7.14.5 CP Guojian Key News
7.15 Biotech
7.15.1 Biotech Corporate Summary
7.15.2 Biotech Business Overview
7.15.3 Biotech Biopharmaceuticals Major Product Offerings
7.15.4 Biotech Biopharmaceuticals Revenue in Global Market (2017-2022)
7.15.5 Biotech Key News
7.16 Gelgen
7.16.1 Gelgen Corporate Summary
7.16.2 Gelgen Business Overview
7.16.3 Gelgen Biopharmaceuticals Major Product Offerings
7.16.4 Gelgen Biopharmaceuticals Revenue in Global Market (2017-2022)
7.16.5 Gelgen Key News
7.17 Innovent
7.17.1 Innovent Corporate Summary
7.17.2 Innovent Business Overview
7.17.3 Innovent Biopharmaceuticals Major Product Offerings
7.17.4 Innovent Biopharmaceuticals Revenue in Global Market (2017-2022)
7.17.5 Innovent Key News
7.18 Dong Bao
7.18.1 Dong Bao Corporate Summary
7.18.2 Dong Bao Business Overview
7.18.3 Dong Bao Biopharmaceuticals Major Product Offerings
7.18.4 Dong Bao Biopharmaceuticals Revenue in Global Market (2017-2022)
7.18.5 Dong Bao Key News
7.19 Ganlee
7.19.1 Ganlee Corporate Summary
7.19.2 Ganlee Business Overview
7.19.3 Ganlee Biopharmaceuticals Major Product Offerings
7.19.4 Ganlee Biopharmaceuticals Revenue in Global Market (2017-2022)
7.19.5 Ganlee Key News
7.20 United Laboratories
7.20.1 United Laboratories Corporate Summary
7.20.2 United Laboratories Business Overview
7.20.3 United Laboratories Biopharmaceuticals Major Product Offerings
7.20.4 United Laboratories Biopharmaceuticals Revenue in Global Market (2017-2022)
7.20.5 United Laboratories Key News
7.21 SANDOZ (NOVARTIS)
7.21.1 SANDOZ (NOVARTIS) Corporate Summary
7.21.2 SANDOZ (NOVARTIS) Business Overview
7.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Major Product Offerings
7.21.4 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue in Global Market (2017-2022)
7.21.5 SANDOZ (NOVARTIS) Key News
7.22 Teva Pharmaceutical
7.22.1 Teva Pharmaceutical Corporate Summary
7.22.2 Teva Pharmaceutical Business Overview
7.22.3 Teva Pharmaceutical Biopharmaceuticals Major Product Offerings
7.22.4 Teva Pharmaceutical Biopharmaceuticals Revenue in Global Market (2017-2022)
7.22.5 Teva Pharmaceutical Key News
7.23 Hospira （Pfizer）
7.23.1 Hospira （Pfizer） Corporate Summary
7.23.2 Hospira （Pfizer） Business Overview
7.23.3 Hospira （Pfizer） Biopharmaceuticals Major Product Offerings
7.23.4 Hospira （Pfizer） Biopharmaceuticals Revenue in Global Market (2017-2022)
7.23.5 Hospira （Pfizer） Key News
7.24 MYLAN
7.24.1 MYLAN Corporate Summary
7.24.2 MYLAN Business Overview
7.24.3 MYLAN Biopharmaceuticals Major Product Offerings
7.24.4 MYLAN Biopharmaceuticals Revenue in Global Market (2017-2022)
7.24.5 MYLAN Key News
7.25 Sun pharma
7.25.1 Sun pharma Corporate Summary
7.25.2 Sun pharma Business Overview
7.25.3 Sun pharma Biopharmaceuticals Major Product Offerings
7.25.4 Sun pharma Biopharmaceuticals Revenue in Global Market (2017-2022)
7.25.5 Sun pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Biopharmaceuticals Market Opportunities & Trends in Global Market
Table 2. Biopharmaceuticals Market Drivers in Global Market
Table 3. Biopharmaceuticals Market Restraints in Global Market
Table 4. Key Players of Biopharmaceuticals in Global Market
Table 5. Top Biopharmaceuticals Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Biopharmaceuticals Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Biopharmaceuticals Revenue Share by Companies, 2017-2022
Table 8. Global Companies Biopharmaceuticals Product Type
Table 9. List of Global Tier 1 Biopharmaceuticals Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biopharmaceuticals Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Biopharmaceuticals Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Biopharmaceuticals Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Biopharmaceuticals Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Biopharmaceuticals Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Biopharmaceuticals Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Biopharmaceuticals Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Biopharmaceuticals Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Biopharmaceuticals Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Biopharmaceuticals Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Biopharmaceuticals Product Offerings
Table 32. Roche Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 33. Amgen Corporate Summary
Table 34. Amgen Biopharmaceuticals Product Offerings
Table 35. Amgen Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 36. AbbVie Corporate Summary
Table 37. AbbVie Biopharmaceuticals Product Offerings
Table 38. AbbVie Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 39. Sanofi-Aventis Corporate Summary
Table 40. Sanofi-Aventis Biopharmaceuticals Product Offerings
Table 41. Sanofi-Aventis Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Biopharmaceuticals Product Offerings
Table 44. Johnson & Johnson Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Biopharmaceuticals Product Offerings
Table 47. Pfizer Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 48. Novo Nordisk Corporate Summary
Table 49. Novo Nordisk Biopharmaceuticals Product Offerings
Table 50. Novo Nordisk Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 51. Eli Lilly Corporate Summary
Table 52. Eli Lilly Biopharmaceuticals Product Offerings
Table 53. Eli Lilly Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 54. Novartis Corporate Summary
Table 55. Novartis Biopharmaceuticals Product Offerings
Table 56. Novartis Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 57. Merck Corporate Summary
Table 58. Merck Biopharmaceuticals Product Offerings
Table 59. Merck Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 60. Sun Corporate Summary
Table 61. Sun Biopharmaceuticals Product Offerings
Table 62. Sun Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 63. 3sbio Corporate Summary
Table 64. 3sbio Biopharmaceuticals Product Offerings
Table 65. 3sbio Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 66. Changchun High Tech Corporate Summary
Table 67. Changchun High Tech Biopharmaceuticals Product Offerings
Table 68. Changchun High Tech Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 69. CP Guojian Corporate Summary
Table 70. CP Guojian Biopharmaceuticals Product Offerings
Table 71. CP Guojian Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 72. Biotech Corporate Summary
Table 73. Biotech Biopharmaceuticals Product Offerings
Table 74. Biotech Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 75. Gelgen Corporate Summary
Table 76. Gelgen Biopharmaceuticals Product Offerings
Table 77. Gelgen Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 78. Innovent Corporate Summary
Table 79. Innovent Biopharmaceuticals Product Offerings
Table 80. Innovent Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 81. Dong Bao Corporate Summary
Table 82. Dong Bao Biopharmaceuticals Product Offerings
Table 83. Dong Bao Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 84. Ganlee Corporate Summary
Table 85. Ganlee Biopharmaceuticals Product Offerings
Table 86. Ganlee Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 87. United Laboratories Corporate Summary
Table 88. United Laboratories Biopharmaceuticals Product Offerings
Table 89. United Laboratories Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 90. SANDOZ (NOVARTIS) Corporate Summary
Table 91. SANDOZ (NOVARTIS) Biopharmaceuticals Product Offerings
Table 92. SANDOZ (NOVARTIS) Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 93. Teva Pharmaceutical Corporate Summary
Table 94. Teva Pharmaceutical Biopharmaceuticals Product Offerings
Table 95. Teva Pharmaceutical Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 96. Hospira （Pfizer） Corporate Summary
Table 97. Hospira （Pfizer） Biopharmaceuticals Product Offerings
Table 98. Hospira （Pfizer） Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 99. MYLAN Corporate Summary
Table 100. MYLAN Biopharmaceuticals Product Offerings
Table 101. MYLAN Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 102. Sun pharma Corporate Summary
Table 103. Sun pharma Biopharmaceuticals Product Offerings
Table 104. Sun pharma Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Biopharmaceuticals Segment by Type in 2021
Figure 2. Biopharmaceuticals Segment by Application in 2021
Figure 3. Global Biopharmaceuticals Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Biopharmaceuticals Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biopharmaceuticals Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biopharmaceuticals Revenue in 2021
Figure 8. By Type - Global Biopharmaceuticals Revenue Market Share, 2017-2028
Figure 9. By Application - Global Biopharmaceuticals Revenue Market Share, 2017-2028
Figure 10. By Region - Global Biopharmaceuticals Revenue Market Share, 2017-2028
Figure 11. By Country - North America Biopharmaceuticals Revenue Market Share, 2017-2028
Figure 12. US Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Biopharmaceuticals Revenue Market Share, 2017-2028
Figure 16. Germany Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 17. France Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Biopharmaceuticals Revenue Market Share, 2017-2028
Figure 24. China Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 28. India Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Biopharmaceuticals Revenue Market Share, 2017-2028
Figure 30. Brazil Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Biopharmaceuticals Revenue Market Share, 2017-2028
Figure 33. Turkey Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AbbVie Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sanofi-Aventis Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novo Nordisk Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eli Lilly Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Novartis Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Merck Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sun Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. 3sbio Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Changchun High Tech Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. CP Guojian Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Biotech Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Gelgen Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Innovent Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Dong Bao Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Ganlee Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. United Laboratories Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. SANDOZ (NOVARTIS) Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Teva Pharmaceutical Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Hospira （Pfizer） Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. MYLAN Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. Sun pharma Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report